We are live on ! Find out more
ALXN

Alexion Pharmaceuticals
ALXN

Delisted

ALXN was delisted on the 20th of July, 2021.

Back to rankings

406 hedge funds and large institutions have $17.3B invested in Alexion Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 406 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

53% more call options, than puts

Call options by funds: $149M | Put options by funds: $97.1M

Holders
406
Holders Change
+406
Holders Change %
–
% of All Funds
13.25%
Holding in Top 10
6
Holding in Top 10 Change
+6
Holding in Top 10 Change %
% of All Funds
0.2%
New
406
Increased
–
Reduced
–
Closed
–
Calls
$149M
Puts
$97.1M
Net Calls
+$51.9M
Net Calls Change
+$51.9M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
MCWS
351
McKinley Carter Wealth Services
West Virginia
$226K +$236K +2,452 New
Verition Fund Management
352
Verition Fund Management
Connecticut
$222K +$232K +2,406 New
ZCM
353
Ziegler Capital Management
Illinois
$221K +$231K +2,397 New
GLI
354
Guardian Life Insurance
New York
$217K +$226K +2,349 New
CCG
355
Cypress Capital Group
Florida
$215K +$225K +2,333 New
ZIM
356
Zacks Investment Management
Illinois
$205K +$214K +2,223 New
Envestnet Asset Management
357
Envestnet Asset Management
Illinois
$197K +$206K +2,135 New
ECM
358
Endex Capital Management
Kansas
$184K +$192K +1,995 New
MFS
359
MSI Financial Services
Massachusetts
$167K +$174K +1,808 New
Northwestern Mutual Wealth Management
360
Northwestern Mutual Wealth Management
Wisconsin
$153K +$159K +1,654 New
SI
361
Stephens Inc
Arkansas
$150K +$157K +1,625 New
GIS
362
Guardian Investor Services
New York
$146K +$153K +1,586 New
GT
363
Glenmede Trust
Pennsylvania
$146K +$154K +1,595 New
MUMSS
364
Mitsubishi UFJ Morgan Stanley Securities
Japan
$127K +$133K +1,380 New
Robeco Institutional Asset Management
365
Robeco Institutional Asset Management
Netherlands
$108K +$113K +1,168 New
WRM
366
Westport Resources Management
Connecticut
$97K +$101K +1,050 New
BPBT
367
Boston Private Bank & Trust
Massachusetts
$95K +$99.5K +1,033 New
SAMC
368
Shinko Asset Management Company
Japan
$92K +$96.4K +1,000 New
OA
369
OFI Advisors
Pennsylvania
$78K +$81.1K +842 New
LIA
370
LS Investment Advisors
Michigan
$62K +$65K +674 New
Fifth Third Bancorp
371
Fifth Third Bancorp
Ohio
$58K +$60.7K +630 New
OMCS
372
Old Mutual Customised Solutions
South Africa
$55K +$57.8K +600 New
FFC
373
First Financial Corp
Indiana
$48K +$50.1K +520 New
Bessemer Group
374
Bessemer Group
New Jersey
$46K +$48.2K +500 New
MAM
375
Mizuho Asset Management
Japan
$41K +$42.5K +441 New
13 14
15
16 17

ALXN Hedge Fund Activity: Q2 2013 in Review

406 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Alexion Pharmaceuticals (ALXN) for Q2 2013, worth a combined $17.3B.

Buyers outnumbered sellers: 406 funds opened new ALXN positions and 0 closed out — a net gain of 406 holders — while 0 added to existing stakes and 0 trimmed.

  • 406 institutional investors held Alexion Pharmaceuticals (ALXN) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $17.3B of Alexion Pharmaceuticals stock for Q2 2013.
  • 406 funds opened new Alexion Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +406 holders.

Based on aggregated 13F filings for Q2 2013.